Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3066% above fair value
$8.30−0.26 (-3.04%)
Close on Nov 13, 2026Market cap $180.76MP/E –Yield –
Alpha Cognition EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Alpha Cognition
Alpha Cognition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?